Literature DB >> 9760123

Widespread programmed cell death in early developing chick optic tectum.

Z Zhang1, D S Galileo.   

Abstract

We demonstrate that widespread programmed cell death exists in proliferative regions of chicken optic tectum during early development using a sensitive fluorescent ISEL method (FISEL+) and antibody staining for an antigen in dying cells. Several developmental stages from embryonic day (E) 3 to E18 were examined. FISEL+-positive cells were rare before E7 and between E9 to E12. However, massive labeling was observed in the ventricular zone (VZ) between stages E7.5 and E8. At this time extensive cell migration is underway and many labeled cells were found not only in the VZ (premigratory cells) but also in the intermediate zone and tectal plate (migratory cells). Many labeled cells were also found in upper tectal laminae at late developmental stages (E15 and E18).

Entities:  

Mesh:

Year:  1998        PMID: 9760123     DOI: 10.1097/00001756-199808240-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Human and rat glioma growth, invasion, and vascularization in a novel chick embryo brain tumor model.

Authors:  Alexandra Cretu; Joseph S Fotos; Brian W Little; Deni S Galileo
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 2.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

3.  Retroviral transfer of antisense integrin alpha6 or alpha8 sequences results in laminar redistribution or clonal cell death in developing brain.

Authors:  Z Zhang; D S Galileo
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

4.  Extrinsic embryonic sensory stimulation alters multimodal behavior and cellular activation.

Authors:  Rebecca G Markham; Toru Shimizu; Robert Lickliter
Journal:  Dev Neurobiol       Date:  2008-11       Impact factor: 3.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.